Marsh & McLennan Companies, Inc. MMC
Set alert
182.70 USD 0.00 0.00%
At close · Jan 13
182.60 -0.10 -0.05%
After hours · Jan 13, 4:00 PM ET
181.83 Day range 185.21
52-week range unavailable
- YTD
- -1.52%
- 1 year
- -21.56%
- Open
- 185.21
- Prev close
- 182.70
- Mkt cap
- 89.82B
- Vol
- 1.18M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 1.97%
More statistics
- Low
- 181.83
- High
- 185.21
- Forward P/E
- 17.72
- Beta
- 0.75
- Short ratio
- 1.90
- Inst. own
- 92.08%
- Dividend
- 3.60
- Ex-div date
- Oct 1, 2025
- Earnings
- Jan 29, 2026
- 50-d avg
- 183.73
- 200-d avg
- 202.15
- 1y target
- 210.71
3M chart
Events in this range
- Oct 16, 2025Earnings: —; estimate 1.79; surprise —%
- Jan 6, 2026Rating: Keefe, Bruyette & Woods · Market Perform → Market Perform
- Jan 7, 2026Rating: JP Morgan · Overweight → Overweight
- Jan 7, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Jan 8, 2026Rating: Barclays · Overweight → Overweight
- Jan 13, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
Signals (22)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| SMA: Bullish | Jan 8, 2026 | 9 months ago |
| SMA: Bearish | Jan 7, 2026 | 10 months ago |
| MACD: Sell Signal | Jan 6, 2026 | 10 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Jan 2, 2026 | 10 months ago |
| SMA: Bearish | Jan 2, 2026 | 10 months ago |
| MACD: Sell Signal | Jan 2, 2026 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 19, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Nov 26, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| RSI: Oversold | Nov 5, 2025 | 12 months ago |
| RSI: Oversold | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 16, 2025 | 1 year ago |
| SMA: Bearish | Oct 16, 2025 | 1 year ago |
Newest 20 of 22.
Analyst view
Consensus: buy
Buy
Price target (mean) 210.71 +15.3% upside
Now 182.70
- Target (low)
- 174.00
- Target (mean)
- 210.71
- Target (high)
- 258.00
Ratings (0m) 23 8 buy · 14 hold · 1 sell
- Strong buy3
- Buy5
- Hold14
- Sell0
- Strong sell1
Recommendation trend
- This month 23
- 1 month ago 23
- 2 months ago 22
- 3 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.97 | 1.92 – 2.01 | 1.87 | +5.5% | 6.55B | +8.0% | 21 |
| Next quarter | 3.23 | 3.16 – 3.28 | 3.06 | +5.5% | 7.43B | +5.3% | 18 |
| Current year | 9.61 | 9.52 – 9.71 | 8.80 | +9.2% | 26.94B | +10.2% | 22 |
| Next year | 10.31 | 10.03 – 10.52 | 9.61 | +7.3% | 28.30B | +5.0% | 22 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 14, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jan 13, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 7, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jan 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jan 6, 2026 | Keefe, Bruyette & Woods | Maintained | Market Perform | Market Perform |
| Dec 16, 2025 | Mizuho | Initiated | — | Outperform |
| Dec 4, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Nov 20, 2025 | Barclays | Upgrade | Equal-Weight | Overweight |
| Nov 3, 2025 | TD Cowen | Maintained | Hold | Hold |
| Nov 3, 2025 | B of A Securities | Downgrade | Neutral | Underperform |
| Oct 20, 2025 | Goldman Sachs | Upgrade | Sell | Neutral |
| Oct 17, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 17, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 17, 2025 | Keefe, Bruyette & Woods | Upgrade | Underperform | Market Perform |
| Oct 9, 2025 | JP Morgan | Upgrade | Neutral | Overweight |
| Oct 8, 2025 | UBS | Maintained | Buy | Buy |
| Oct 8, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 8, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 7, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 16, 2025 | Wolfe Research | Initiated | — | Peer Perform |
| Aug 18, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 13, 2025 | Citigroup | Initiated | — | Neutral |
| Jul 21, 2025 | UBS | Maintained | Buy | Buy |
| Jul 21, 2025 | Keefe, Bruyette & Woods | Maintained | Underperform | Underperform |
| Jul 18, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 10, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 9, 2025 | Keefe, Bruyette & Woods | Maintained | Underperform | Underperform |
| Jul 7, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 21, 2025 | Keefe, Bruyette & Woods | Maintained | Underperform | Underperform |